{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T16:00:39Z","timestamp":1790611239520,"version":"4.1.0"},"reference-count":162,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ibroneuroscience.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.neuroscience.2025.12.012","type":"journal-article","created":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T16:14:00Z","timestamp":1765296840000},"page":"171-183","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Genetic predispositions and nutritional strategies: a review of nutrigenomics in Parkinson\u2019s disease"],"prefix":"10.1016","volume":"593","author":[{"given":"Yara Ahmed","family":"Mohamed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayten Ahmed","family":"Ahmed Nadeem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4483-9134","authenticated-orcid":false,"given":"Lina M.","family":"Ismail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-1264-0689","authenticated-orcid":false,"given":"Youssef K.","family":"Ghallab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5036-2144","authenticated-orcid":false,"given":"Relwend\u00e9 Justin","family":"Ou\u00e9draogo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1221-4554","authenticated-orcid":false,"given":"Jana","family":"Elhelw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Zeeshan","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Engy K.","family":"Tharwat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuroscience.2025.12.012_b0005","doi-asserted-by":"crossref","unstructured":"Abolarin, P.O., Amin, A., Nafiu, A.B., Ogundele, O.M., Owoyele, B.V. 2024. Optimization of Parkinson\u2019s disease therapy with plant extracts and nutrition\u2019s evolving roles. Vol. 17, IBRO Neuroscience Reports. Elsevier B.V., p. 1\u201312.","DOI":"10.1016\/j.ibneur.2024.05.011"},{"issue":"7","key":"10.1016\/j.neuroscience.2025.12.012_b0010","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.2174\/1570159X19666211116142806","article-title":"How to optimize the effectiveness and safety of parkinson\u2019s disease therapy? \u2013 A systematic review of drugs interactions with food and dietary supplements","volume":"20","author":"Agnieszka","year":"2021","journal-title":"Curr. Neuropharmacol."},{"issue":"2","key":"10.1016\/j.neuroscience.2025.12.012_b0015","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1080\/0361073X.2021.1959823","article-title":"Behavioral, biochemical and histopathological effects of standardised Pomegranate extract with Vinpocetine, Propolis or Cocoa in a rat model of Parkinson\u2019s disease","volume":"48","author":"Ali","year":"2022","journal-title":"Exp. Aging Res."},{"issue":"4","key":"10.1016\/j.neuroscience.2025.12.012_b0020","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s13353-015-0282-9","article-title":"Genomic instability in the PARK2 locus is associated with Parkinson\u2019s disease","volume":"56","author":"Ambroziak","year":"2015","journal-title":"J. Appl. Genet."},{"issue":"5","key":"10.1016\/j.neuroscience.2025.12.012_b0025","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1002\/ana.20666","article-title":"DJ-1 mutations and parkinsonism-dementia-amyotrophic lateral sclerosis complex","volume":"58","author":"Annesi","year":"2005","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuroscience.2025.12.012_b0030","doi-asserted-by":"crossref","DOI":"10.7759\/cureus.70337","article-title":"The impact of diet on Parkinson\u2019s disease: a systematic review","author":"Anwar","year":"2024","journal-title":"Cureus"},{"issue":"4","key":"10.1016\/j.neuroscience.2025.12.012_b0035","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1080\/07315724.2019.1582980","article-title":"Personalized nutrition: translating the science of nutrigenomics into practice: proceedings from the 2018 american college of nutrition meeting","volume":"38","author":"Aruoma","year":"2019","journal-title":"J. Am. Coll. Nutr."},{"issue":"12","key":"10.1016\/j.neuroscience.2025.12.012_b0040","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/S1474-4422(16)30230-7","article-title":"The epidemiology of Parkinson\u2019s disease: risk factors and prevention","volume":"15","author":"Ascherio","year":"2016","journal-title":"Lancet Neurol."},{"issue":"12","key":"10.1016\/j.neuroscience.2025.12.012_b0045","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/S1474-4422(16)30230-7","article-title":"The epidemiology of Parkinson\u2019s disease: risk factors and prevention","volume":"15","author":"Ascherio","year":"2016","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neuroscience.2025.12.012_b0050","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25042393","article-title":"Protein translation in the pathogenesis of Parkinson\u2019s disease","volume":"25","author":"Ashraf","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.neuroscience.2025.12.012_b0055","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/ene.14108","article-title":"Parkinson disease","volume":"27","author":"Balestrino","year":"2020","journal-title":"Eur. J. Neurol."},{"issue":"3","key":"10.1016\/j.neuroscience.2025.12.012_b0060","first-page":"213","article-title":"Vitamin E and other antioxidants in neuroprotection","volume":"69","author":"Behl","year":"1999","journal-title":"IJVNR"},{"key":"10.1016\/j.neuroscience.2025.12.012_b0065","article-title":"Model-based dietary optimization for late-stage, levodopa-treated, Parkinson\u2019s disease patients","volume":"2","author":"Ben","year":"2016","journal-title":"NPJ Syst. Biol. Appl."},{"key":"10.1016\/j.neuroscience.2025.12.012_b0070","doi-asserted-by":"crossref","unstructured":"Benede\u223ci MS, Dostert P. 1989. MONOAMINE OXIDASE, BRAIN AGEING AND DEGENERATIVE DISEASES. Vol. 38, Biochemical Pharmacology.","DOI":"10.1016\/0006-2952(89)90198-6"},{"issue":"3","key":"10.1016\/j.neuroscience.2025.12.012_b0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1096\/fj.04-2106fje","article-title":"Acetylcholinesterase\/paraoxonase interactions increase the risk of insecticide-induced Parkinson\u2019s disease","volume":"19","author":"Benmoyal-Segal","year":"2005","journal-title":"FASEB J."},{"key":"10.1016\/j.neuroscience.2025.12.012_b0080","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s00441-018-2817-y","article-title":"Genetic risk factors in Parkinson\u2019s disease","volume":"373","author":"Billingsley","year":"2018","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.neuroscience.2025.12.012_b0085","doi-asserted-by":"crossref","DOI":"10.3390\/nu11081896","article-title":"Nutritional risk factors, microbiota and parkinson\u2019s disease: what is the current evidence?","volume":"11","author":"Boulos","year":"2019","journal-title":"Nutrients"},{"issue":"2","key":"10.1016\/j.neuroscience.2025.12.012_b0090","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1093\/hmg\/ddn340","article-title":"Lack of replication of association between GIGYF2 variants and Parkinson disease","volume":"18","author":"Bras","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuroscience.2025.12.012_b0095","article-title":"Sinemet-ferrous sulphate interaction in patients with Parkinson\u2019s disease","volume":"30","author":"Campbell","year":"1990","journal-title":"J. Clin. Pharmac."},{"key":"10.1016\/j.neuroscience.2025.12.012_b0100","doi-asserted-by":"crossref","unstructured":"Canet-Avil\u00e9, R.M., Wilson, M.A., Miller, D.W., Ahmad, R., Mclendon, C., Bandyopadhyay, S., et al. 2004. The Parkinson\u2019s disease protein DJ-1 is neuroprotective due to cysteine-sulfinic acid-driven mitochondrial localization [Internet]. Available from: www.pnas.orgcgidoi10.1073pnas.0402959101.","DOI":"10.1073\/pnas.0402959101"},{"issue":"APR","key":"10.1016\/j.neuroscience.2025.12.012_b0105","article-title":"Expression analysis of the long non-coding RNA antisense to Uchl1 (AS Uchl1) during dopaminergic cells\u2019 differentiation in vitro and in neurochemical models of Parkinson\u2019s disease","volume":"9","author":"Carrieri","year":"2015","journal-title":"Front. Cell. Neurosci."},{"issue":"1","key":"10.1016\/j.neuroscience.2025.12.012_b0110","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1093\/ajcn\/84.1.252","article-title":"Concentrated red grape juice exerts antioxidant, hypolipidemic, and antiinflammatory effects in both hemodialysis patients and healthy subjects2","volume":"84","author":"Castilla","year":"2006","journal-title":"Am. J. Clin. Nutr."},{"issue":"5","key":"10.1016\/j.neuroscience.2025.12.012_b0115","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1212\/WNL.50.5.1458","article-title":"A genetic polymorphism of MAO-B modifies the association of cigarette smoking and Parkinson\u2019s disease","volume":"50","author":"Checkoway","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.neuroscience.2025.12.012_b0120","doi-asserted-by":"crossref","unstructured":"Chen, X., Silva, H.A.R. de, Pettenati, M.J. 1995. The human NACP\/{alpha}-synuclein gene: Chromosome assignment to 4q21.3-q22 and TaqI RFLP analysis. 26. Available from: https:\/\/www.osti.gov\/biblio\/219914.","DOI":"10.1016\/0888-7543(95)80237-G"},{"key":"10.1016\/j.neuroscience.2025.12.012_b0125","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2022.997266","article-title":"Recent advances in nutrigenomics: making strides towards precision nutrition","volume":"13","author":"Cole","year":"2022","journal-title":"Front. Genet."},{"issue":"40","key":"10.1016\/j.neuroscience.2025.12.012_b0130","doi-asserted-by":"crossref","first-page":"192.e1","DOI":"10.1016\/j.neurobiolaging.2016.01.003","article-title":"FBXO7 mutations in Parkinson\u2019s disease and multiple system atrophy","volume":"1","author":"Conedera","year":"2016","journal-title":"Neurobiol. Aging"},{"issue":"9","key":"10.1016\/j.neuroscience.2025.12.012_b0135","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a009415","article-title":"Parkinsonism due to mutations in PINK1, Parkin, and DJ-1 and oxidative stress and mitochondrial pathways","volume":"2","author":"Cookson","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"issue":"13","key":"10.1016\/j.neuroscience.2025.12.012_b0140","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1002\/mds.25784","article-title":"DNA methylation of the MAPT gene in Parkinson\u2019s disease cohorts and modulation by vitamin E in vitro","volume":"29","author":"Coupland","year":"2014","journal-title":"Mov. Disord."},{"issue":"24","key":"10.1016\/j.neuroscience.2025.12.012_b0145","first-page":"e3428","article-title":"Association of caffeine and related analytes with resistance to Parkinson disease among LRRK2 mutation carriers","volume":"95","author":"Crotty","year":"2020","journal-title":"Neurology [Internet]."},{"key":"10.1016\/j.neuroscience.2025.12.012_b0150","first-page":"1571","article-title":"The efficacy of ketogenic therapies in the clinical management of people with neurodegenerative disease: a systematic review","volume":"Vol. 12","author":"Dewsbury","year":"2021"},{"issue":"6","key":"10.1016\/j.neuroscience.2025.12.012_b0155","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1111\/j.1471-4159.1989.tb07264.x","article-title":"Increased nigral iron content and alterations in other metal ions occurring in brain in Parkinson\u2019s disease","volume":"52","author":"Dexter","year":"1989","journal-title":"J. Neurochem."},{"issue":"10","key":"10.1016\/j.neuroscience.2025.12.012_b0160","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1007\/s40265-022-01747-7","article-title":"Newly approved and investigational drugs for motor symptom control in Parkinson\u2019s disease","volume":"82","author":"Di Luca","year":"2022","journal-title":"Drugs"},{"key":"10.1016\/j.neuroscience.2025.12.012_b0165","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21072564","article-title":"Bioactive polyphenols and neuromodulation: molecular mechanisms in neurodegeneration","volume":"21","author":"Di Meo","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuroscience.2025.12.012_b0170","doi-asserted-by":"crossref","DOI":"10.7759\/cureus.34657","article-title":"A review of genetic and gene therapy for Parkinson\u2019s disease","author":"Dumbhare","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.neuroscience.2025.12.012_b0175","doi-asserted-by":"crossref","unstructured":"Dyall, S.C. 2015. Long-chain omega-3 fatty acids and the brain: A review of the independent and shared effects of EPA, DPA and DHA. Vol. 7, Frontiers in Aging Neuroscience. Frontiers Research Foundation.","DOI":"10.3389\/fnagi.2015.00052"},{"issue":"3","key":"10.1016\/j.neuroscience.2025.12.012_b0180","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1001\/archneur.62.3.353","article-title":"Molecular pathogenesis of Parkinson disease","volume":"62","author":"Eriksen","year":"2005","journal-title":"Arch. Neurol."},{"issue":"2","key":"10.1016\/j.neuroscience.2025.12.012_b0185","first-page":"69","article-title":"Nutrigenetics and nutrigenomics: viewpoints on the current status and applications in nutrition research and practice","volume":"4","author":"Fenech","year":"2011","journal-title":"J. Nutrigenet .Nutrigenomics"},{"key":"10.1016\/j.neuroscience.2025.12.012_b0190","doi-asserted-by":"crossref","unstructured":"Gan-Or, Z., Liong, C., Alcalay, R.N. 2017. GBA-Associated Parkinson\u2019s Disease and Other Synucleinopathies. Vol. 18, Current Neurology and Neuroscience Reports. Current Medicine Group LLC 1.","DOI":"10.1007\/s11910-018-0860-4"},{"key":"10.1016\/j.neuroscience.2025.12.012_b0195","doi-asserted-by":"crossref","DOI":"10.3390\/nu13061951","article-title":"Mediterranean diet as an antioxidant: the impact on metabolic health and overall wellbeing","volume":"13","author":"Gantenbein","year":"2021","journal-title":"Nutrients"},{"key":"10.1016\/j.neuroscience.2025.12.012_b0200","doi-asserted-by":"crossref","unstructured":"Gardener, H., Caunca, M.R. 2018. Mediterranean Diet in Preventing Neurodegenerative Diseases. Vol. 7, Current Nutrition Reports. Current Science Inc. p. 10\u201320.","DOI":"10.1007\/s13668-018-0222-5"},{"issue":"23","key":"10.1016\/j.neuroscience.2025.12.012_b0205","doi-asserted-by":"crossref","first-page":"6467","DOI":"10.1080\/10408398.2021.1902261","article-title":"Nutritional aspects in Parkinson\u2019s disease","volume":"62","author":"G\u0105tarek","year":"2022","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"10.1016\/j.neuroscience.2025.12.012_b0210","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1146\/annurev.food.102308.124147","article-title":"Nutrigenomics and personalized diets: what will they mean for food?","volume":"2","author":"German","year":"2011","journal-title":"Annu. Rev. Food Sci. Technol."},{"issue":"4","key":"10.1016\/j.neuroscience.2025.12.012_b0215","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s00702-025-02901-7","article-title":"Nutritional and dietary clinical trials for Parkinson\u2019s disease: a narrative review","volume":"132","author":"Giannakis","year":"2025","journal-title":"J. Neural. Transm."},{"issue":"2","key":"10.1016\/j.neuroscience.2025.12.012_b0220","article-title":"Potential therapeutic effects of polyphenols in Parkinson\u2019s disease: in vivo: and: in vitro: pre-clinical studies","volume":"16","author":"Giuliano","year":"2021","journal-title":"Neural Regen Res."},{"key":"10.1016\/j.neuroscience.2025.12.012_b0225","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1146\/annurev-pharmtox-011613-135937","article-title":"Environmental toxins and Parkinson\u2019s disease","volume":"54","author":"Goldman","year":"2014","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.neuroscience.2025.12.012_b0230","article-title":"Neuroprotection by the ketogenic diet: evidence and controversies","volume":"8","author":"Gough","year":"2021","journal-title":"Front. Nutrit."},{"issue":"10","key":"10.1016\/j.neuroscience.2025.12.012_b0235","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1002\/mnfr.201600111","article-title":"Resveratrol alleviates MPTP-induced motor impairments and pathological changes by autophagic degradation of \u03b1-synuclein via SIRT1-deacetylated LC3","volume":"60","author":"Guo","year":"2016","journal-title":"Mol. Nutr. Food Res."},{"issue":"3","key":"10.1016\/j.neuroscience.2025.12.012_b0240","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.neulet.2009.03.039","article-title":"GIGYF2 Asn56Ser and Asn457Thr mutations in Parkinson disease patients","volume":"454","author":"Guo","year":"2009","journal-title":"Neurosci. Lett."},{"issue":"5","key":"10.1016\/j.neuroscience.2025.12.012_b0245","doi-asserted-by":"crossref","DOI":"10.3892\/wasj.2025.374","article-title":"Role of the microbiome in the development of Parkinson\u2019s disease (review)","volume":"7","author":"Gushi","year":"2025","journal-title":"World Acad. Sci. J."},{"key":"10.1016\/j.neuroscience.2025.12.012_b0250","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1111\/j.1365-2990.2007.00874.x","article-title":"Parkinson\u2019s disease: a dual-hit hypothesis","volume":"33","author":"Hawkes","year":"2007","journal-title":"Neuropathol. Appl. Neurobiol."},{"issue":"8","key":"10.1016\/j.neuroscience.2025.12.012_b0255","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1212\/01.WNL.0000142089.38301.8E","article-title":"PINK1 (PARK6) associated Parkinson disease in Ireland","volume":"63","author":"Healy","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.neuroscience.2025.12.012_b0260","doi-asserted-by":"crossref","unstructured":"Henrich, M.T., Oertel, W.H., Surmeier, D.J., Geibl, F.F. 2023. Mitochondrial dysfunction in Parkinson\u2019s disease \u2013 a key disease hallmark with therapeutic potential. Vol. 18, Molecular Neurodegeneration. BioMed Central Ltd; 2023.","DOI":"10.1186\/s13024-023-00676-7"},{"key":"10.1016\/j.neuroscience.2025.12.012_b0265","doi-asserted-by":"crossref","DOI":"10.1186\/s13024-023-00676-7","article-title":"Mitochondrial dysfunction in Parkinson\u2019s disease \u2013 a key disease hallmark with therapeutic potential","volume":"18","author":"Henrich","year":"2023","journal-title":"Mol. Neurodegeneration"},{"key":"10.1016\/j.neuroscience.2025.12.012_b0270","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/jnc.13593","article-title":"Genetics in Parkinson disease: Mendelian versus non-Mendelian inheritance","author":"Hernandez","year":"2016","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuroscience.2025.12.012_b0275","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/humu.20676","article-title":"Gaucher disease: mutation and polymorphism spectrum in the glucocerebrosidase gene (GBA)","volume":"29","author":"Hruska","year":"2008","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.neuroscience.2025.12.012_b0280","doi-asserted-by":"crossref","unstructured":"Hsieh, P.C., Wang, C.C., Tsai, C.L., Yeh, Y.M., Lee, Y.S., Wu, Y.R. 2019. POLG R964C and GBA L444P mutations in familial Parkinson\u2019s disease: Case report and literature review. Vol. 9, Brain and Behavior. John Wiley and Sons Ltd.","DOI":"10.1002\/brb3.1281"},{"key":"10.1016\/j.neuroscience.2025.12.012_b0285","doi-asserted-by":"crossref","unstructured":"Irimie, A.I., Braicu, C., Pasca, S., Magdo, L., Gulei, D., Cojocneanu, R., et al. 2019. Role of key micronutrients from nutrigenetic and nutrigenomic perspectives in cancer prevention. Vol. 55, Medicina (Lithuania). MDPI AG.","DOI":"10.3390\/medicina55060283"},{"key":"10.1016\/j.neuroscience.2025.12.012_b0290","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2025.1592280","article-title":"Curcumin and neuroplasticity: epigenetic mechanisms underlying cognitive enhancement in aging and neurodegenerative disorders","volume":"17","author":"Jiao","year":"2025","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.neuroscience.2025.12.012_b0295","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.tins.2018.09.007","article-title":"Triggers, facilitators, and aggravators: redefining Parkinson\u2019s disease pathogenesis","volume":"42","author":"Johnson","year":"2019","journal-title":"Trends Neurosci."},{"issue":"18","key":"10.1016\/j.neuroscience.2025.12.012_b0300","doi-asserted-by":"crossref","first-page":"6355","DOI":"10.1523\/JNEUROSCI.6119-09.2010","article-title":"Methylation regulates alpha-synuclein expression and is decreased in Parkinson\u2019s disease patients\u2019 brains","volume":"30","author":"Jowaed","year":"2010","journal-title":"J. Neurosci."},{"issue":"10","key":"10.1016\/j.neuroscience.2025.12.012_b0305","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1002\/mds.25125","article-title":"Parkinson\u2019s disease and other neurodegenerative disorders among welders: a Danish cohort study","volume":"27","author":"Kenborg","year":"2012","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neuroscience.2025.12.012_b0310","doi-asserted-by":"crossref","DOI":"10.3390\/nu14153112","article-title":"The potential of the Mediterranean diet to improve mitochondrial function in experimental models of obesity and metabolic syndrome","volume":"14","author":"Khalil","year":"2022","journal-title":"Nutrients"},{"issue":"6676","key":"10.1016\/j.neuroscience.2025.12.012_b0315","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/33416","article-title":"Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism","volume":"392","author":"Kitada","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.neuroscience.2025.12.012_b0320","doi-asserted-by":"crossref","unstructured":"Klann, E.M., Dissanayake, U., Gurrala, A., Farrer, M., Shukla, A.W., Ramirez-Zamora, A., et al. 2022. The Gut\u2013Brain Axis and Its Relation to Parkinson\u2019s Disease: A Review. Vol. 13, Frontiers in Aging Neuroscience. Frontiers Media S.A.","DOI":"10.3389\/fnagi.2021.782082"},{"issue":"1","key":"10.1016\/j.neuroscience.2025.12.012_b0325","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a008888","article-title":"Genetics of Parkinson\u2019s disease","volume":"2","author":"Klein","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.neuroscience.2025.12.012_b0330","doi-asserted-by":"crossref","DOI":"10.3390\/nu14214472","article-title":"The role of diet and dietary patterns in Parkinson\u2019s disease","volume":"14","author":"Knight","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/j.neuroscience.2025.12.012_b0335","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.3233\/JPD-223380","article-title":"Early-onset Parkinson\u2019s disease: creating the right environment for a genetic disorder","volume":"12","author":"Kolicheski","year":"2022","journal-title":"J. Parkinson\u2019s Dis."},{"issue":"22","key":"10.1016\/j.neuroscience.2025.12.012_b0340","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.parkreldis.2015.09.007","article-title":"Autosomal dominant Parkinson\u2019s disease caused by SNCA duplications","volume":"1","author":"Konno","year":"2016","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.neuroscience.2025.12.012_b0345","doi-asserted-by":"crossref","DOI":"10.3390\/nu10050642","article-title":"Polyphenols in Parkinson\u2019s disease: a systematic review of in vivo studies","volume":"10","author":"Kujawska","year":"2018","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.neuroscience.2025.12.012_b0350","doi-asserted-by":"crossref","DOI":"10.1038\/s41531-024-00681-7","article-title":"Diet and the gut microbiome in patients with Parkinson\u2019s disease","volume":"10","author":"Kwon","year":"2024","journal-title":"NPJ Parkinsons Dis."},{"key":"10.1016\/j.neuroscience.2025.12.012_b0355","doi-asserted-by":"crossref","unstructured":"Lagoumintzis, G., Patrinos, G.P. 2023. Triangulating nutrigenomics, metabolomics and microbiomics toward personalized nutrition and healthy living. Vol. 17, Human Genomics. BioMed Central Ltd.","DOI":"10.1186\/s40246-023-00561-w"},{"issue":"4","key":"10.1016\/j.neuroscience.2025.12.012_b0360","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.ajhg.2008.01.015","article-title":"Mutations in the GIGYF2 (TNRC15) gene at the PARK11 locus in familial Parkinson disease","volume":"82","author":"Lautier","year":"2008","journal-title":"Am. J. Hum. Genet."},{"issue":"R1","key":"10.1016\/j.neuroscience.2025.12.012_b0365","doi-asserted-by":"crossref","first-page":"R48","DOI":"10.1093\/hmg\/ddp012","article-title":"Parkinson\u2019s disease: from monogenic forms to genetic susceptibility factors","volume":"18","author":"Lesage","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuroscience.2025.12.012_b0370","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/1750-1326-9-47","article-title":"The role of the LRRK2 gene in Parkinsonism","volume":"9","author":"Li","year":"2014","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.neuroscience.2025.12.012_b0375","first-page":"615","article-title":"Mitochondria-mediated damage to dopaminergic neurons in Parkinson\u2019s disease (Review)","volume":"41","author":"Liu","year":"2018","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.neuroscience.2025.12.012_b0380","article-title":"Unraveling Parkinson\u2019s disease: the mystery of mitochondria and the role of aging","author":"Liu","year":"2025","journal-title":"Genes Dis."},{"key":"10.1016\/j.neuroscience.2025.12.012_b0385","doi-asserted-by":"crossref","DOI":"10.3390\/cells8070712","article-title":"Mitophagy in Parkinson\u2019s disease: from pathogenesis to treatment","volume":"8","author":"Liu","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.neuroscience.2025.12.012_b0390","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.2147\/NDT.S254065","article-title":"Lack of association between pla2g6 genetic variation and Parkinson\u2019s disease: a systematic review","volume":"16","author":"Liu","year":"2020","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.neuroscience.2025.12.012_b0395","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/cells10020283","article-title":"Interaction between Parkin and \u03b1-Synuclein in park2-mediated Parkinson\u2019s disease","volume":"10","author":"Madsen","year":"2021","journal-title":"Cells"},{"issue":"4","key":"10.1016\/j.neuroscience.2025.12.012_b0400","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1111\/ene.15698","article-title":"Mediterranean diet is associated with a lower probability of prodromal Parkinson\u2019s disease and risk for Parkinson\u2019s disease\/dementia with Lewy bodies: a longitudinal study","volume":"30","author":"Maraki","year":"2023","journal-title":"Eur. J. Neurol."},{"issue":"1","key":"10.1016\/j.neuroscience.2025.12.012_b0405","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.cell.2011.06.001","article-title":"Gaucher disease glucocerebrosidase and \u03b1-synuclein form a bidirectional pathogenic loop in synucleinopathies","volume":"146","author":"Mazzulli","year":"2011","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.neuroscience.2025.12.012_b0410","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.neurobiolaging.2009.02.016","article-title":"GIGYF2 has no major role in Parkinson genetic etiology in a Belgian population","volume":"32","author":"Meeus","year":"2011","journal-title":"Neurobiol. Aging"},{"issue":"14","key":"10.1016\/j.neuroscience.2025.12.012_b0415","doi-asserted-by":"crossref","DOI":"10.3390\/nu17142330","article-title":"Beyond MIND and mediterranean diets: designing a diet to optimize Parkinson\u2019s disease outcomes","volume":"17","author":"Mischley","year":"2025","journal-title":"Nutrients"},{"issue":"5","key":"10.1016\/j.neuroscience.2025.12.012_b0420","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.3945\/ajcn.2009.28789","article-title":"FADS1 FADS2 gene variants modify the association between fish intake and the docosahexaenoic acid proportions in human milk1234","volume":"91","author":"Molt\u00f3-Puigmart\u00ed","year":"2010","journal-title":"Am. J. Clin. Nutr."},{"issue":"4","key":"10.1016\/j.neuroscience.2025.12.012_b0425","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1002\/cpt.1548","article-title":"N-acetyl cysteine is associated with dopaminergic improvement in Parkinson\u2019s disease","volume":"106","author":"Monti","year":"2019","journal-title":"Clin. Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.neuroscience.2025.12.012_b0430","doi-asserted-by":"crossref","DOI":"10.1186\/s13024-024-00766-0","article-title":"Gut-first Parkinson\u2019s disease is encoded by gut dysbiome","volume":"19","author":"Munoz-Pinto","year":"2024","journal-title":"Mol. Neurodegener."},{"issue":"6","key":"10.1016\/j.neuroscience.2025.12.012_b0435","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1002\/mds.26192","article-title":"Genetic risk and age in Parkinson\u2019s disease: continuum not stratum","volume":"30","author":"Nalls","year":"2015","journal-title":"Mov. Disord."},{"issue":"12","key":"10.1016\/j.neuroscience.2025.12.012_b0440","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/S1474-4422(19)30320-5","article-title":"Identification of novel risk loci, causal insights, and heritable risk for Parkinson\u2019s disease: a meta-analysis of genome-wide association studies","volume":"18","author":"Nalls","year":"2019","journal-title":"Lancet Neurol."},{"issue":"12","key":"10.1016\/j.neuroscience.2025.12.012_b0445","first-page":"A582","article-title":"Nutrigenomics: the genome-food interface","volume":"115","author":"Nathaniel","year":"2007","journal-title":"Environ. Health Perspect."},{"issue":"9","key":"10.1016\/j.neuroscience.2025.12.012_b0450","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1093\/qjmed\/89.9.691","article-title":"Occurrence of Parkinson\u2019s syndrome in type 1 Gaucher disease","volume":"89","author":"Neudorfer","year":"1996","journal-title":"QJM"},{"key":"10.1016\/j.neuroscience.2025.12.012_b0455","doi-asserted-by":"crossref","unstructured":"Neufeld, P.M., Nettersheim, R.A., Matschke, V., Vorgerd, M., Stahlke, S., Theiss, C. 2024. Unraveling the gut-brain axis: the impact of steroid hormones and nutrition on Parkinson\u2019s disease. Vol. 19, Neural Regeneration Research. Wolters Kluwer Medknow Publications. p. 2219\u20132228.","DOI":"10.4103\/1673-5374.391304"},{"key":"10.1016\/j.neuroscience.2025.12.012_b0460","article-title":"Caffeine intake interacts with Asian gene variants in Parkinson\u2019s disease: a study in 4488 subjects","volume":"40","author":"Ong","year":"2023","journal-title":"Lancet Reg. Health West Pac."},{"key":"10.1016\/j.neuroscience.2025.12.012_b0465","first-page":"40","article-title":"Caffeine intake interacts with Asian gene variants in Parkinson\u2019s disease: a study in 4488 subjects","volume":"1","author":"Ong","year":"2023","journal-title":"Lancet Reg. Health West Pac."},{"key":"10.1016\/j.neuroscience.2025.12.012_b0470","doi-asserted-by":"crossref","DOI":"10.3390\/molecules23113019","article-title":"Nutritional regulators of Bcl-xL in the brain","volume":"23","author":"Park","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.neuroscience.2025.12.012_b0475","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/antiox9070570","article-title":"Dietary antioxidants and Parkinson\u2019s disease","volume":"9","author":"Park","year":"2020","journal-title":"Antioxidants"},{"issue":"1","key":"10.1016\/j.neuroscience.2025.12.012_b0480","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s11011-021-00800-w","article-title":"Neurodegenerative disorders of Alzheimer, Parkinsonism, amyotrophic lateral sclerosis and multiple sclerosis: an early diagnostic approach for precision treatment","volume":"37","author":"Pathak","year":"2022","journal-title":"Metab. Brain Dis."},{"issue":"8","key":"10.1016\/j.neuroscience.2025.12.012_b0485","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1002\/mds.27390","article-title":"Low-fat versus ketogenic diet in Parkinson\u2019s disease: a pilot randomized controlled trial","volume":"33","author":"Phillips","year":"2018","journal-title":"Mov. Disord."},{"issue":"10","key":"10.1016\/j.neuroscience.2025.12.012_b0490","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1001\/archneur.1987.00520220012007","article-title":"Plasma levels of amino acids correlate with motor fluctuations in Parkinsonism","volume":"44","author":"Pincus","year":"1987","journal-title":"Arch. Neurol."},{"issue":"10","key":"10.1016\/j.neuroscience.2025.12.012_b0495","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2025-101946","article-title":"Modified Mediterranean diet effects on Parkinson\u2019s disease (MED-PARK): a single-centre randomised controlled trial protocol","volume":"15","author":"Pirovano","year":"2025","journal-title":"BMJ Open"},{"key":"10.1016\/j.neuroscience.2025.12.012_b0500","doi-asserted-by":"crossref","unstructured":"Polito, L., Greco, A., Seripa, D. 2016. Genetic Profile, Environmental Exposure, and Their Interaction in Parkinson\u2019s Disease. Vol. 2016, Parkinson\u2019s Disease. Hindawi Limited.","DOI":"10.1155\/2016\/6465793"},{"issue":"5321","key":"10.1016\/j.neuroscience.2025.12.012_b0505","first-page":"2045","article-title":"Mutation in the \u03b1-synuclein gene identified in families with Parkinson\u2019s disease","volume":"276","author":"Polymeropoulos","year":"1997","journal-title":"Science (1979)"},{"issue":"10","key":"10.1016\/j.neuroscience.2025.12.012_b0510","doi-asserted-by":"crossref","first-page":"4887","DOI":"10.1097\/MS9.0000000000001142","article-title":"Parkinson\u2019s disease updates: addressing the pathophysiology, risk factors, genetics, diagnosis, along with the medical and surgical treatment","volume":"85","author":"Prajjwal","year":"2023","journal-title":"Ann. Med. Surg."},{"issue":"2","key":"10.1016\/j.neuroscience.2025.12.012_b0515","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.cmet.2016.12.022","article-title":"Multi-dimensional roles of ketone bodies in fuel metabolism, signaling, and therapeutics","volume":"25","author":"Puchalska","year":"2017","journal-title":"Cell Metab."},{"key":"10.1016\/j.neuroscience.2025.12.012_b0520","unstructured":"Quik, M., Kulak, J.M. Nicotine and Nicotinic Receptors; Relevance to Parkinson\u2019s Disease."},{"key":"10.1016\/j.neuroscience.2025.12.012_b0525","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1186\/s40478-020-01062-w","article-title":"PINK1\/PARKIN signalling in neurodegeneration and neuroinflammation","volume":"8","author":"Quinn","year":"2020","journal-title":"Acta Neuropathol. Commun."},{"issue":"1\u20132","key":"10.1016\/j.neuroscience.2025.12.012_b0530","first-page":"43","article-title":"Guide for current nutrigenetic, nutrigenomic, and nutriepigenetic approaches for precision nutrition involving the prevention and management of chronic diseases associated with obesity","volume":"10","author":"Ramos-Lopez","year":"2017","journal-title":"J. Nutrigenet. Nutrigenomics"},{"issue":"13","key":"10.1016\/j.neuroscience.2025.12.012_b0535","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.ibneur.2022.10.003","article-title":"Integrating nutriepigenomics in Parkinson\u2019s disease management: new promising strategy in the omics era","volume":"1","author":"Razali","year":"2022","journal-title":"IBRO Neurosci. Rep."},{"key":"10.1016\/j.neuroscience.2025.12.012_b0540","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2020.601225","article-title":"Comparison of three motor subtype classifications in de novo Parkinson\u2019s disease patients","volume":"11","author":"Ren","year":"2020","journal-title":"Front. Neurol."},{"key":"10.1016\/j.neuroscience.2025.12.012_b0545","article-title":"The influence of protein containing meals on the pharmacokinetics of levodopa in healthy volunteers","volume":"31","author":"Robertson","year":"1991","journal-title":"J. Clin. Pharm."},{"issue":"1","key":"10.1016\/j.neuroscience.2025.12.012_b0550","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1080\/1028415X.2021.2017662","article-title":"Nutrigenomics in Parkinson\u2019s disease: diversity of modulatory actions of polyphenols on epigenetic effects induced by toxins","volume":"26","author":"Rodrigues-Costa","year":"2023","journal-title":"Nutr. Neurosci."},{"issue":"20","key":"10.1016\/j.neuroscience.2025.12.012_b0555","doi-asserted-by":"crossref","first-page":"2674","DOI":"10.1001\/jama.283.20.2674","article-title":"Association of coffee and caffeine intake with the risk of Parkinson disease","volume":"283","author":"Ross","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.neuroscience.2025.12.012_b0560","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.794640","article-title":"Mediterranean diet adherence in people with Parkinson\u2019s Disease reduces constipation symptoms and changes fecal microbiota after a 5-week single-arm pilot study","volume":"12","author":"Rusch","year":"2021","journal-title":"Front. Neurol."},{"key":"10.1016\/j.neuroscience.2025.12.012_b0565","doi-asserted-by":"crossref","unstructured":"Saleh, S.M.S., Nasser, N., Tharwat, E.K., Elbehiry, T., Helmy, H.I. 2025. Chapter 1 - Neuroinflammation, glymphatic system, and Parkinson\u2019s disease. In: Mohamed W, editor. Translational Models of Parkinson\u2019 s Disease and Related Movement Disorders [Internet]. Academic Press; p. 3\u201327. Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/B9780443161285000013.","DOI":"10.1016\/B978-0-443-16128-5.00001-3"},{"key":"10.1016\/j.neuroscience.2025.12.012_b0570","doi-asserted-by":"crossref","unstructured":"S.M.S. Saleh, N. Nasser, E.K. Tharwat, T. Elbehiry, H.I. Helmy. 2025. Chapter 1 - Neuroinflammation, glymphatic system, and Parkinson\u2019s disease. In: Mohamed W, editor. Translational Models of Parkinson\u2019s Disease and Related Movement Disorders [Internet]. Academic Press; 2025. p. 3\u201327. Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/B9780443161285000013.","DOI":"10.1016\/B978-0-443-16128-5.00001-3"},{"issue":"8649","key":"10.1016\/j.neuroscience.2025.12.012_b0575","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/S0140-6736(89)92366-0","article-title":"Mitochondrial complex I deficiency in Parkinson\u2019s disease","volume":"333","author":"Schapira","year":"1989","journal-title":"The Lancet [Internet]"},{"key":"10.1016\/j.neuroscience.2025.12.012_b0580","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/nrn.2017.62","article-title":"Non-motor features of Parkinson disease","volume":"18","author":"Schapira","year":"2017","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuroscience.2025.12.012_b0585","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1002\/mds.22314","article-title":"Complicated recessive dystonia parkinsonism syndromes","volume":"24","author":"Schneider","year":"2009","journal-title":"Mov. Disord."},{"issue":"12","key":"10.1016\/j.neuroscience.2025.12.012_b0590","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/S1474-4422(23)00370-8","article-title":"Classic ketogenic diet versus further antiseizure medicine in infants with drug-resistant epilepsy (KIWE): a UK, multicentre, open-label, randomised clinical trial","volume":"22","author":"Schoeler","year":"2023","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neuroscience.2025.12.012_b0595","first-page":"67","article-title":"Genetic basis of Parkinson\u2019s disease: inheritance, penetrance, and expression","volume":"4","author":"Schulte","year":"2011","journal-title":"Appl. Clin. Genet."},{"key":"10.1016\/j.neuroscience.2025.12.012_b0600","doi-asserted-by":"crossref","DOI":"10.1083\/jcb.137.1.79","article-title":"Endosome to Golgi retrieval of the vacuolar protein sorting receptor, Vps10p, requires the function of the VPS29 , VPS30 , and VPS35 gene products","volume":"137","author":"Seaman","year":"1997","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.neuroscience.2025.12.012_b0605","doi-asserted-by":"crossref","DOI":"10.3390\/nu16142181","article-title":"Mediterranean diet adherence, gut microbiota and Parkinson\u2019s disease: a systematic review","volume":"16","author":"Seelarbokus","year":"2024","journal-title":"Nutrients"},{"key":"10.1016\/j.neuroscience.2025.12.012_b0610","first-page":"1134","article-title":"Advanced nutraceutical approaches to Parkinson\u2019s disease: bridging nutrition and neuroprotection","volume":"Vol. 28","author":"Sharma","year":"2025"},{"issue":"AUG","key":"10.1016\/j.neuroscience.2025.12.012_b0615","article-title":"Early-onset parkinson\u2019s disease caused by pla2g6 compound heterozygous mutation, a case report and literature review","volume":"10","author":"Shen","year":"2019","journal-title":"Front. Neurol."},{"issue":"3","key":"10.1016\/j.neuroscience.2025.12.012_b0620","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1002\/ana.410360305","article-title":"Alterations in glutathione levels in Parkinson\u2019s disease and other neurodegenerative disorders affecting basal ganglia","volume":"36","author":"Sian","year":"1994","journal-title":"Ann. Neurol."},{"issue":"11","key":"10.1016\/j.neuroscience.2025.12.012_b0625","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/S1474-4422(12)70190-4","article-title":"The link between the GBA gene and Parkinsonism","volume":"11","author":"Sidransky","year":"2012","journal-title":"Lancet Neurol."},{"issue":"1","key":"10.1016\/j.neuroscience.2025.12.012_b0630","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cger.2019.08.002","article-title":"Parkinson disease epidemiology, pathology, genetics, and pathophysiology","volume":"36","author":"Simon","year":"2020","journal-title":"Clin. Geriatr. Med."},{"key":"10.1016\/j.neuroscience.2025.12.012_b0635","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105840","article-title":"The role of microbiota-gut-brain axis in neuropsychiatric and neurological disorders","volume":"172","author":"Soca\u0142a","year":"2021","journal-title":"Pharmacol. Res."},{"issue":"5","key":"10.1016\/j.neuroscience.2025.12.012_b0640","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1111\/j.1469-1809.2009.00529.x","article-title":"The reduced folate carrier (SLC19A1) c.80G > a polymorphism is associated with red cell folate concentrations among women","volume":"73","author":"Stanis\u0142awska-Sachadyn","year":"2009","journal-title":"Ann. Hum. Genet."},{"key":"10.1016\/j.neuroscience.2025.12.012_b0645","unstructured":"Steck, S.E., Gammon, M.D., Hebert, J.R., Wall, D.E., Zeisel, S.H. GSTM1, GSTT1, GSTP1, and GSTA1 Polymorphisms and Urinary Isothiocyanate Metabolites following Broccoli Consumption in Humans 1."},{"issue":"15","key":"10.1016\/j.neuroscience.2025.12.012_b0650","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1093\/hmg\/ddi215","article-title":"Loss of function mutations in the gene encoding Omi\/HtrA2 in Parkinson\u2019s disease","volume":"14","author":"Strauss","year":"2005","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuroscience.2025.12.012_b0655","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.neuroscience.2023.10.007","article-title":"Gene signals and SNPs associated with Parkinson\u2019s disease: a nutrigenomics and computational prospective insights","volume":"533","author":"Subramaniyan","year":"2023","journal-title":"Neuroscience"},{"issue":"3 SUPPL.","key":"10.1016\/j.neuroscience.2025.12.012_b0660","article-title":"The disease intersection of susceptibility and exposure: chemical exposures and neurodegenerative disease risk","volume":"10","author":"Tanner","year":"2014","journal-title":"Alzheimer\u2019s Dement."},{"issue":"2","key":"10.1016\/j.neuroscience.2025.12.012_b0665","article-title":"Mortalin\/Hspa9 involvement and therapeutic perspective in Parkinson\u2019s disease","volume":"18","author":"Texier","year":"2023","journal-title":"Neural Regen. Res."},{"issue":"5","key":"10.1016\/j.neuroscience.2025.12.012_b0670","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1007\/s11011-023-01189-4","article-title":"Evaluation of the therapeutic potential of cerebrolysin and\/or lithium in the male Wistar rat model of Parkinson\u2019s disease induced by reserpine","volume":"38","author":"Tharwat","year":"2023","journal-title":"Metab. Brain Dis. [Internet]"},{"key":"10.1016\/j.neuroscience.2025.12.012_b0675","doi-asserted-by":"crossref","unstructured":"Tharwat, E.K., Hatem, H., Sameh, A., Sultan, B.A., Yehia, S., Abdelazeem, O.A. 2025. Chapter 4 - OMICS and bioinformatics in Parkinson disease and related movements disorders. In: Mohamed W, editor. Translational Models of Parkinson\u2019 s Disease and Related Movement Disorders [Internet]. Academic Press; 2025. p. 65\u201382. Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/B9780443161285000049.","DOI":"10.1016\/B978-0-443-16128-5.00004-9"},{"key":"10.1016\/j.neuroscience.2025.12.012_b0680","doi-asserted-by":"crossref","unstructured":"Tharwat, E.K., Sameh, A., Hatem, H., Abdelazeem, O.A., Saleh, S.M.S. 2025. Chapter 5 - Modeling Parkinson\u2019s disease with the alpha-synuclein protein. In: Mohamed W, editor. Translational Models of Parkinson\u2019 s Disease and Related Movement Disorders [Internet]. Academic Press; p. 83\u201395. Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/B9780443161285000050.","DOI":"10.1016\/B978-0-443-16128-5.00005-0"},{"key":"10.1016\/j.neuroscience.2025.12.012_b0685","doi-asserted-by":"crossref","DOI":"10.1080\/17582024.2024.2352394","article-title":"Impact of a keto diet on symptoms of Parkinson\u2019s disease, biomarkers, depression, anxiety and quality of life: a longitudinal study","author":"Tidman","year":"2024","journal-title":"Neurodegener. Dis. Manage."},{"key":"10.1016\/j.neuroscience.2025.12.012_b0690","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.3233\/JPD-230264","article-title":"The role of diet in Parkinson\u2019s disease","volume":"14","author":"Tosefsky","year":"2024","journal-title":"J. Parkinson\u2019s Dis."},{"issue":"11","key":"10.1016\/j.neuroscience.2025.12.012_b0695","doi-asserted-by":"crossref","first-page":"4902","DOI":"10.1038\/s41380-023-02251-4","article-title":"Mitochondrial DNA damage triggers spread of Parkinson\u2019s disease-like pathology","volume":"28","author":"Tresse","year":"2023","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neuroscience.2025.12.012_b0700","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3233\/JPD-160989","article-title":"PINK1, parkin, and mitochondrial quality control: what can we learn about Parkinson\u2019s disease pathobiology?","volume":"7","author":"Truban","year":"2017","journal-title":"J. Parkinson\u2019s Dis."},{"key":"10.1016\/j.neuroscience.2025.12.012_b0705","unstructured":"Tsai, C.H., Lo, S.K., See, L.C., Chen, H.Z., Chen, R.S., Weng, Y.H., et al. Environmental risk factors of young onset Parkinson\u2019s disease: a case-control study [Internet]. Available from: www.cmch.org.tw."},{"key":"10.1016\/j.neuroscience.2025.12.012_b0710","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines8070201","article-title":"Mediterranean diet as a tool to combat inflammation and chronic diseases. An overview","volume":"8","author":"Tsigalou","year":"2020","journal-title":"Biomedicines"},{"issue":"1","key":"10.1016\/j.neuroscience.2025.12.012_b0715","article-title":"Dietary interventions in Parkinson\u2019s disease","volume":"14","author":"Van Der Berg","year":"2024","journal-title":"J. Parkinsons Dis."},{"issue":"1","key":"10.1016\/j.neuroscience.2025.12.012_b0720","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/ng.491","article-title":"Somatic mutations of the Parkinson\u2019s disease-associated gene PARK2 in glioblastoma and other human malignancies","volume":"42","author":"Veeriah","year":"2010","journal-title":"Nat. Genet."},{"issue":"18","key":"10.1016\/j.neuroscience.2025.12.012_b0725","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.15252\/embj.201593585","article-title":"Loss of FBXO 7 (PARK 15) results in reduced proteasome activity and models a parkinsonism\u2010like phenotype in mice","volume":"35","author":"Vingill","year":"2016","journal-title":"EMBO J."},{"key":"10.1016\/j.neuroscience.2025.12.012_b0730","series-title":"Molecular Neurobiology","first-page":"353","article-title":"Food, nutrigenomics, and neurodegeneration - neuroprotection by what you eat!","author":"Virmani","year":"2013"},{"issue":"13","key":"10.1016\/j.neuroscience.2025.12.012_b0735","doi-asserted-by":"crossref","first-page":"8447","DOI":"10.1074\/jbc.M114.627463","article-title":"Functional significance of point mutations in stress chaperone mortalin and their relevance to Parkinson disease *","volume":"290","author":"Wadhwa","year":"2015","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.neuroscience.2025.12.012_b0740","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e12877","article-title":"Vitamin D and neurodegenerative diseases","volume":"9","author":"Wang","year":"2023","journal-title":"Heliyon"},{"key":"10.1016\/j.neuroscience.2025.12.012_b0745","doi-asserted-by":"crossref","unstructured":"Warnecke, T., Sch\u00e4fer, K.H., Claus, I., Del Tredici, K., Jost, W.H. 2022. Gastrointestinal involvement in Parkinson\u2019s disease: pathophysiology, diagnosis, and management. Vol. 8, NPJ Parkinson\u2019s Disease. Nature Research.","DOI":"10.1038\/s41531-022-00295-x"},{"issue":"13","key":"10.1016\/j.neuroscience.2025.12.012_b0750","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1002\/mds.25217","article-title":"Polychlorinated biphenyls in prospectively collected serum and Parkinson\u2019s disease risk","volume":"27","author":"Weisskopf","year":"2012","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neuroscience.2025.12.012_b0755","doi-asserted-by":"crossref","first-page":"219","DOI":"10.3233\/JPD-161020","article-title":"VPS35, the retromer complex and Parkinson\u2019s disease","volume":"7","author":"Williams","year":"2017","journal-title":"J. Parkinson\u2019s Dis."},{"issue":"10","key":"10.1016\/j.neuroscience.2025.12.012_b0760","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1002\/mds.20511","article-title":"Kufor Rakeb disease: autosomal recessive, levodopa-responsive Parkinsonism with pyramidal degeneration, supranuclear gaze palsy, and dementia","volume":"20","author":"Williams","year":"2005","journal-title":"Mov. Disord."},{"issue":"3","key":"10.1016\/j.neuroscience.2025.12.012_b0765","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1006\/jmbi.2001.5386","article-title":"Crystallographic studies on human BST-1\/CD157 with ADP-ribosyl cyclase and NAD glycohydrolase activities","volume":"316","author":"Yamamoto-Katayama","year":"2002","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.neuroscience.2025.12.012_b0770","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/5288698","article-title":"Dietary plant polyphenols as the potential drugs in neurodegenerative diseases: current evidence, advances, and opportunities","volume":"2022","author":"Yan","year":"2022","journal-title":"Oxid. Med. Cell. Longevity"},{"issue":"12","key":"10.1016\/j.neuroscience.2025.12.012_b0775","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000014852","article-title":"Effect of statins on Parkinson\u2019s disease: a systematic review and meta-analysis","volume":"98","author":"Yan","year":"2019","journal-title":"Medicine"},{"key":"10.1016\/j.neuroscience.2025.12.012_b0780","doi-asserted-by":"crossref","unstructured":"Yang, F., Lagerros, Y.T., Bellocco, R., Adami, H.O., Fang, F., Pedersen, N.L., et al. Physical activity and risk of Parkinson\u2019s disease in the Swedish National March Cohort. Available from: https:\/\/academic.oup.com\/brain\/article\/138\/2\/269\/291630.","DOI":"10.1093\/brain\/awu323"},{"key":"10.1016\/j.neuroscience.2025.12.012_b0785","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2023.114811","article-title":"Mitochondrial homeostasis regulation: a promising therapeutic target for Parkinson\u2019s disease","volume":"459","author":"Yao","year":"2024","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuroscience.2025.12.012_b0790","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abp8701","article-title":"Ca2+ channels couple spiking to mitochondrial metabolism in substantia Nigra dopaminergic neurons","volume":"8","author":"Zampese","year":"2022","journal-title":"Sci. Adv."},{"issue":"9","key":"10.1016\/j.neuroscience.2025.12.012_b0795","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1002\/mds.21243","article-title":"Macrogol for the treatment of constipation in Parkinson\u2019s disease. A randomized placebo-controlled study","volume":"22","author":"Zangaglia","year":"2007","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neuroscience.2025.12.012_b0800","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2024.1273874","article-title":"Correlation between dietary factors and Parkinson\u2019s disease revealed by the analysis of Mendelian randomization","volume":"11","author":"Zeng","year":"2024","journal-title":"Front. Nutr."},{"key":"10.1016\/j.neuroscience.2025.12.012_b0805","article-title":"Role of DJ-1 in immune and inflammatory diseases","volume":"11","author":"Zhang","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.neuroscience.2025.12.012_b0810","article-title":"Sulforaphane protects against rotenone-induced neurotoxicity in vivo: Involvement of the mTOR, Nrf2, and autophagy pathways","volume":"24","author":"Zhou","year":"2016","journal-title":"Sci. Rep."}],"container-title":["Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452225011601?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452225011601?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T17:08:37Z","timestamp":1770224917000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306452225011601"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":162,"alternative-id":["S0306452225011601"],"URL":"https:\/\/doi.org\/10.1016\/j.neuroscience.2025.12.012","relation":{},"ISSN":["0306-4522"],"issn-type":[{"value":"0306-4522","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genetic predispositions and nutritional strategies: a review of nutrigenomics in Parkinson\u2019s disease","name":"articletitle","label":"Article Title"},{"value":"Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuroscience.2025.12.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 International Brain Research Organization (IBRO). Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}